Insider Trading activities of Dusa Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dusa Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dusa Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Dusa Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is DUSA. The reporting company's CIK number is 879993.
The total value of stock buying since 2005 is $901,530.
The total value of stock sales since 2005 is $8,807,427.
The total value of stock option exercises since 2005 is $601,221.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dusa Pharmaceuticals Inc (DUSA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2012-11 0 $0 0 $0 7,500 $12,000
2012-03 0 $0 36,875 $214,296 81,875 $207,590
2011-08 5,000 $20,269 0 $0 0 $0
2011-05 0 $0 125,725 $745,056 125,725 $293,381
2011-03 0 $0 1,130,965 $5,058,223 20,000 $31,100
2010-08 7,000 $16,770 0 $0 0 $0
2010-06 0 $0 0 $0 15,000 $16,500
2010-03 10,000 $17,180 0 $0 0 $0
2009-12 56,722 $73,236 0 $0 0 $0
2009-06 423,000 $380,700 0 $0 0 $0
2009-03 250,000 $302,500 0 $0 0 $0
2009-02 0 $0 29,848 $31,939 0 $0
2008-12 0 $0 579,994 $661,193 0 $0
2008-11 0 $0 102,048 $146,720 0 $0
2008-10 6,300 $6,300 0 $0 0 $0
2008-08 5,000 $8,650 0 $0 0 $0
2007-11 10,000 $20,735 0 $0 0 $0
2007-09 0 $0 1,000,000 $1,950,000 0 $0
2007-05 3,000 $8,520 0 $0 15,000 $40,650
2006-03 7,000 $46,670 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Dusa Pharmaceuticals Inc insiders (DUSA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-11-13 Christopher Richard (VP Finance & CFO) Option Ex 7,500 1.60 12,000
2012-03-16 Lundahl Scott L (VP, Regulatory Affairs & IP) Sale 17,500 5.79 101,360
2012-03-16 Lundahl Scott L (VP, Regulatory Affairs & IP) Option Ex 17,500 1.60 28,000
2012-03-13 Haft Jay M (Director) Option Ex 20,000 2.70 54,100
2012-03-12 Marcus Stuart L (VP, Sc. Aff & CMO) Sale 19,375 5.83 112,936
2012-03-12 Marcus Stuart L (VP, Sc. Aff & CMO) Option Ex 19,375 2.74 52,990
2012-03-08 Bartash David M (Director) Option Ex 25,000 2.90 72,500
2011-08-11 Altomari Alfred (Director) Buy 2,000 4.06 8,119
2011-08-09 Haft Jay M (Director) Buy 3,000 4.05 12,150
2011-05-16 Lundahl Scott L (VP, Regulatory Affairs & IP) Sale 1,000 5.96 5,960
2011-05-16 Lundahl Scott L (VP, Regulatory Affairs & IP) Option Ex 1,000 1.22 1,220
2011-05-13 Carota Mark (Vice President, Operations) Sale 36,875 5.90 217,378
2011-05-13 Carota Mark (Vice President, Operations) Option Ex 36,875 2.23 82,231
2011-05-13 Lundahl Scott L (VP, Regulatory Affairs & IP) Sale 17,500 5.95 104,125
2011-05-13 Lundahl Scott L (VP, Regulatory Affairs & IP) Option Ex 17,500 3.87 67,725
2011-05-12 Todisco Michael (Vice President, Controller) Sale 27,800 5.92 164,464
2011-05-12 Todisco Michael (Vice President, Controller) Option Ex 27,800 1.22 33,916
2011-05-12 Christopher Richard (VP Finance & CFO) Sale 42,550 5.95 253,129
2011-05-12 Christopher Richard (VP Finance & CFO) Option Ex 42,550 2.54 108,289
2011-03-22 Deerfield Special Situations Fund International Ltd Sale 94,000 4.34 408,242
2011-03-21 Deerfield Special Situations Fund International Ltd Sale 93,224 4.56 425,567
2011-03-18 Deerfield Special Situations Fund International Ltd Sale 3,200 4.61 14,752
2011-03-17 Deerfield Special Situations Fund International Ltd Sale 447,111 4.59 2,052,686
2011-03-16 Deerfield Special Situations Fund International Ltd Sale 68,430 4.58 313,751
2011-03-15 Deerfield Special Situations Fund International Ltd Sale 425,000 4.34 1,843,225
2011-03-08 Moliteus Magnus (Director) Option Ex 20,000 1.56 31,100
2010-08-30 Wurzer David M (Director) Buy 5,000 2.35 11,730
2010-08-05 Altomari Alfred (Director) Buy 2,000 2.52 5,040
2010-06-08 Lesser Marvin E (Director) Option Ex 15,000 1.10 16,500
2010-03-05 Haft Jay M (Director) Buy 10,000 1.72 17,180
2009-12-17 Lundahl Scott L (VP, Regulatory Affairs & IP) Buy 16,722 1.32 22,156
2009-12-17 Abeles John H (Director) Buy 20,000 1.30 25,960
2009-12-16 Abeles John H (Director) Buy 20,000 1.26 25,120
2009-06-25 Deerfield Special Situations Fund International Lt (10% Owner) Buy 423,000 .90 380,700
2009-03-11 Deerfield Special Situations Fund International Lt (10% Owner) Buy 250,000 1.21 302,500
2009-02-24 Deerfield Special Situations Fund International Lt (10% Owner) Sale 200 1.08 216
2009-02-23 Deerfield Special Situations Fund International Lt (10% Owner) Sale 29,648 1.07 31,723
2008-12-02 Becker Steven R (10% Owner) Sale 579,994 1.14 661,193
2008-11-18 Becker Steven R (10% Owner) Sale 16,948 1.20 20,371
2008-11-13 Becker Steven R (10% Owner) Sale 8,700 1.48 12,910
2008-11-12 Becker Steven R (10% Owner) Sale 19,600 1.50 29,400
2008-11-07 Becker Steven R (10% Owner) Sale 18,400 1.54 28,244
2008-11-06 Becker Steven R (10% Owner) Sale 38,400 1.45 55,795
2008-10-23 Becker Steven R (10% Owner) Buy 6,300 1.00 6,300
2008-08-22 Doman Robert F (President and CEO) Buy 5,000 1.73 8,650
2007-11-13 Doman Robert F (President and COO) Buy 5,000 2.10 10,485
2007-11-13 Abeles John H (Director) Buy 5,000 2.05 10,250
2007-09-10 Cooper Hill Partners Llc (10% Owner) Sale 1,000,000 1.95 1,950,000
2007-05-15 Doman Robert F (President and COO) Buy 3,000 2.84 8,520
2007-05-14 Moliteus Magnus (Director) Option Ex 15,000 2.71 40,650
2006-03-17 Doman Robert F (President and COO) Buy 2,000 6.66 13,320
2006-03-17 Shulman D Geoffrey (Chairman of the Board & CEO) Buy 5,000 6.67 33,350

Insider trading activities including stock purchases, stock sales, and option exercises of DUSA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dusa Pharmaceuticals Inc (symbol DUSA, CIK number 879993) see the Securities and Exchange Commission (SEC) website.